These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

697 related items for PubMed ID: 9174617

  • 1. Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees.
    BenMohamed L, Gras-Masse H, Tartar A, Daubersies P, Brahimi K, Bossus M, Thomas A, Druilhe P.
    Eur J Immunol; 1997 May; 27(5):1242-53. PubMed ID: 9174617
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A novel Plasmodium falciparum sporozoite and liver stage antigen (SALSA) defines major B, T helper, and CTL epitopes.
    Bottius E, BenMohamed L, Brahimi K, Gras H, Lepers JP, Raharimalala L, Aikawa M, Meis J, Slierendregt B, Tartar A, Thomas A, Druilhe P.
    J Immunol; 1996 Apr 15; 156(8):2874-84. PubMed ID: 8609407
    [Abstract] [Full Text] [Related]

  • 4. Immunization of mice with lipopeptides bypasses the prerequisite for adjuvant. Immune response of BALB/c mice to human immunodeficiency virus envelope glycoprotein.
    Martinon F, Gras-Masse H, Boutillon C, Chirat F, Deprez B, Guillet JG, Gomard E, Tartar A, Levy JP.
    J Immunol; 1992 Nov 15; 149(10):3416-22. PubMed ID: 1385524
    [Abstract] [Full Text] [Related]

  • 5. Characterization of regulatory T-cell responses in humans induced by the P. Falciparum blood stage antigen Pf155/RESA.
    Troye-Blomberg M, Olerup O, Perlmann H, Larsson A, Elghazali G, Fogdell A, Jepsen A, Lepers JP, Pandey JP, Grunewald J.
    Behring Inst Mitt; 1994 Dec 15; (95):97-105. PubMed ID: 7755513
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Immune responses to defined epitopes of the circumsporozoite protein of the murine malaria parasite, Plasmodium yoelii.
    Grillot D, Michel M, Müller I, Tougne C, Rènia L, Mazier D, Corradin G, Lambert PH, Louis JA, Del Guidice G.
    Eur J Immunol; 1990 Jun 15; 20(6):1215-22. PubMed ID: 1695152
    [Abstract] [Full Text] [Related]

  • 9. Induction of protective CTL responses against the Plasmodium yoelii circumsporozoite protein by immunization with peptides.
    Franke ED, Corradin G, Hoffman SL.
    J Immunol; 1997 Oct 01; 159(7):3424-33. PubMed ID: 9317141
    [Abstract] [Full Text] [Related]

  • 10. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT, Kobs-Conrad S, Seo YH, Lee H, VanBuskirk AM, Feng N, Sheridan JF, Stevens V.
    J Mol Recognit; 1993 Jun 01; 6(2):81-94. PubMed ID: 7508238
    [Abstract] [Full Text] [Related]

  • 11. Long-term multiepitopic cytotoxic-T-lymphocyte responses induced in chimpanzees by combinations of Plasmodium falciparum liver-stage peptides and lipopeptides.
    BenMohamed L, Thomas A, Druilhe P.
    Infect Immun; 2004 Aug 01; 72(8):4376-84. PubMed ID: 15271893
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. High immunogenicity in chimpanzees of peptides and lipopeptides derived from four new Plasmodium falciparum pre-erythrocytic molecules.
    Benmohamed L, Thomas A, Bossus M, Brahimi K, Wubben J, Gras-Masse H, Druilhe P.
    Vaccine; 2000 Jun 15; 18(25):2843-55. PubMed ID: 10812228
    [Abstract] [Full Text] [Related]

  • 14. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa.
    Dobaño C, Doolan DL.
    Mol Immunol; 2007 Apr 15; 44(11):3037-48. PubMed ID: 17303242
    [Abstract] [Full Text] [Related]

  • 15. Immunogenicity of multiple antigen peptides containing B and non-repeat T cell epitopes of the circumsporozoite protein of Plasmodium falciparum.
    Calvo-Calle JM, de Oliveira GA, Clavijo P, Maracic M, Tam JP, Lu YA, Nardin EH, Nussenzweig RS, Cochrane AH.
    J Immunol; 1993 Feb 15; 150(4):1403-12. PubMed ID: 7679427
    [Abstract] [Full Text] [Related]

  • 16. Protection against malaria by Plasmodium yoelii sporozoite surface protein 2 linear peptide induction of CD4+ T cell- and IFN-gamma-dependent elimination of infected hepatocytes.
    Wang R, Charoenvit Y, Corradin G, De La Vega P, Franke ED, Hoffman SL.
    J Immunol; 1996 Nov 01; 157(9):4061-7. PubMed ID: 8892640
    [Abstract] [Full Text] [Related]

  • 17. Long synthetic peptides encompassing the Plasmodium falciparum LSA3 are the target of human B and T cells and are potent inducers of B helper, T helper and cytolytic T cell responses in mice.
    Perlaza BL, Sauzet JP, Balde AT, Brahimi K, Tall A, Corradin G, Druilhe P.
    Eur J Immunol; 2001 Jul 01; 31(7):2200-9. PubMed ID: 11449374
    [Abstract] [Full Text] [Related]

  • 18. Immunization with synthetic peptides containing a defined malaria epitope induces a highly diverse cytotoxic T lymphocyte response. Evidence that two peptide residues are buried in the MHC molecule.
    Romero P, Eberl G, Casanova JL, Cordey AS, Widmann C, Luescher IF, Corradin G, Maryanski JL.
    J Immunol; 1992 Mar 15; 148(6):1871-8. PubMed ID: 1541825
    [Abstract] [Full Text] [Related]

  • 19. Peptide immunization can elicit malaria protein-specific memory helper but not proliferative T cells.
    Good MF, Branigan J, Smith G, Houghten RA.
    Pept Res; 1990 Mar 15; 3(3):110-5. PubMed ID: 1724615
    [Abstract] [Full Text] [Related]

  • 20. "Universal" T helper cell determinants enhance immunogenicity of a Plasmodium falciparum merozoite surface antigen peptide.
    Kumar A, Arora R, Kaur P, Chauhan VS, Sharma P.
    J Immunol; 1992 Mar 01; 148(5):1499-505. PubMed ID: 1371529
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.